Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
Stopped early · Phase 2
Conditions studied: Breast Cancer
In brief
RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Drugs used in chemotherapy, such as docetaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving trastuzumab together with docetaxel and carboplatin may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving trastuzumab together with docetaxel and carboplatin works in treating women with stage II, stage III, or inflammatory breast cancer.
Key facts
- Study ID
- NCT00118053
- Run by
- University of Medicine and Dentistry of New Jersey
- People needed
- 5
- Starts
- 2005-04-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2013-11-20
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Central Jersey Oncology Center, PA - East Brunswick — East Brunswick, New Jersey, United States
- CentraState Medical Center — Freehold, New Jersey, United States
- Cancer Institute of New Jersey at Hamilton — Hamilton, New Jersey, United States
- Mountainside Hospital Cancer Center — Montclair, New Jersey, United States
- Carol G. Simon Cancer Center at Morristown Memorial Hospital — Morristown, New Jersey, United States
- Saint Peter's University Hospital — New Brunswick, New Jersey, United States
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
- UMDNJ University Hospital — Newark, New Jersey, United States
- Overlook Hospital — Summit, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.